KPV Peptides for Sale: Analytical-Grade Tripeptide for In Vitro and Preclinical Research

Sourcing Analytical-Grade KPV Peptides for Laboratory Research

When sourcing KPV peptides for sale for in vitro or preclinical animal models, research institutions require fully verified, analytical-grade compounds with complete lot traceability. KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) evaluated extensively for its localized anti-inflammatory mechanisms in mucosal and intestinal barrier models. PX1 Research provides high-purity KPV 5mg lyophilized powder manufactured under strict quality controls for laboratory evaluation.

In academic and pharmaceutical research, experimental reliability hinges on compound purity and batch-to-batch consistency. Impurities such as truncated peptide sequences, residual solvents, or heavy metals can confound cell culture assays and alter signaling cascade measurements. Every lot of KPV provided by PX1 Research undergoes rigorous testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS), ensuring that investigators receive a compound meeting strict physical and chemical parameters.

Molecular Structure and Derivation of the KPV Tripeptide

KPV is a synthetic tripeptide consisting of the L-amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). Structurally, it represents the amino acid residues 11 through 13 located at the C-terminus of alpha-melanocyte-stimulating hormone (alpha-MSH). While the native 13-amino-acid alpha-MSH peptide exhibits broad melanocortin receptor agonist activity across multiple receptor subtypes (MC1R through MC5R), the truncated KPV sequence exhibits distinct physical and functional properties.

With a molecular weight of approximately 341.45 g/mol, KPV is significantly smaller and more hydrophilic than parent melanocortin peptides. This lower molecular weight enhances its structural stability against rapid enzymatic degradation in extracellular matrices. Preclinical studies suggest that KPV retains potent anti-inflammatory signaling capabilities without eliciting the full pigmentary or melanogenic pathways associated with systemic MC1R activation, making it a valuable target for isolated inflammatory response research.

Intracellular Signaling and NF-κB Pathway Modulation

The primary mechanism of action investigated for KPV involves its interaction with intracellular inflammatory signaling cascades, most notably the Nuclear Factor kappa B (NF-κB) pathway. In vitro assays using intestinal epithelial cell lines demonstrate that KPV is transported across cell membranes via the oligopeptide transporter PepT1 (SLC15A1), which is frequently upregulated in inflamed epithelial tissue.

Once internalized, preclinical models indicate that KPV acts intracellularly to inhibit the translocation of the NF-κB p65 subunit into the nucleus. By preventing p65 nuclear entry, KPV downregulates the transcription of major pro-inflammatory cytokines, including Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), Interleukin-8 (IL-8), and Tumor Necrosis Factor-alpha (TNF-α). Additionally, KPV has been observed to attenuate inducible nitric oxide synthase (iNOS) expression, thereby reducing excess intracellular reactive nitrogen species (RNS) during simulated inflammatory stress.

Preclinical Literature: KPV in Intestinal Barrier and Colitis Models

A substantial portion of the published literature regarding KPV focuses on mucosal immunity and intestinal epithelial integrity. In murine models of chemical-induced colitis—such as Dextran Sulfate Sodium (DSS) and Trinitrobenzenesulfonic acid (TNBS) models—investigators have used KPV to study localized tissue repair and cytokine suppression within the gastrointestinal tract.

Preclinical data show that administration of KPV in these rodent models correlates with significant reductions in histological inflammation scores, decreased mucosal myeloperoxidase (MPO) activity (a marker of neutrophil infiltration), and preservation of crypt architecture. Furthermore, in vitro epithelial monolayer experiments (e.g., Caco-2 cell models) demonstrate that KPV treatment helps maintain trans-epithelial electrical resistance (TEER) and prevents the downregulation of key tight junction proteins such as Zonula Occludens-1 (ZO-1), occludin, and claudins following exposure to inflammatory stimuli.

Comparative Analysis: KPV vs. Other Mucosal & Anti-Inflammatory Compounds

To properly contextualize experimental designs, investigators often compare KPV against other research peptides targeting epithelial tissue recovery and systemic inflammatory pathways. Understanding the mechanistic differences between these agents is critical when selecting controls or designing combination protocols within our research peptide library.

While KPV operates primarily via PepT1-mediated cell entry and direct NF-κB nuclear translocation blockade, BPC-157 5mg exerts mucosal protective effects through focal adhesion kinase (FAK) signaling, VEGFR2 activation, and nitric oxide pathway modulation, as described in BPC-157 mucosal research. Conversely, Larazotide acetate acts specifically as a tight junction antagonist targeting zonula occludens pathways to prevent paracellular permeability, rather than directly inhibiting intracellular cytokine transcription. Comparing KPV with parent alpha-MSH variants also reveals that while full-length melanocortins rely heavily on classical surface receptor binding, KPV's primary pathway utilizes peptide transporter uptake for intracellular signaling.

Supplier Quality Standards for KPV Research Peptides

When purchasing KPV peptides for sale, research laboratories must evaluate critical analytical metrics to ensure experimental reproducibility. Low-purity peptide batches often contain unreacted chemical reagents, truncated synthesis fragments, or excess counter-ions (such as trifluoroacetate) that alter cellular osmolarity and confound experimental readouts.

PX1 Research enforces stringent quality assurance criteria for every production lot:

• **Purity Verification via RP-HPLC:** All KPV lots are verified to exceed 98.0% chemical purity, ensuring minimal baseline noise in sensitive cell culture or enzymatic assays.

• **Mass Spectrometry (ESI-MS):** High-resolution mass spectrometry confirms exact molecular mass (341.45 g/mol) and identity, eliminating cross-contamination risks.

• **Lot-Specific Certificate of Analysis (COA):** Comprehensive COAs detailing analytical chromatograms and mass spectra are publicly available for every batch.

• **USA Manufacturing & ISO Standards:** Synthesized in GMP-compliant facilities and tested by ISO 17025 accredited partner laboratories within the United States.

Endotoxin Control and Bioburden Considerations

For researchers conducting delicate cell culture, organoid, or in vivo rodent studies, endotoxin contamination presents a major confounding variable. Lipopolysaccharides (LPS), or endotoxins derived from Gram-negative bacterial cell walls, induce severe inflammatory responses via Toll-Like Receptor 4 (TLR4) signaling, directly interfering with assays measuring cytokine expression.

PX1 Research subjects KPV lots to rigorous Bacterial Endotoxin Testing (BET) using quantitative Chromogenic Limulus Amebocyte Lysate (LAL) assays. By enforcing strict endotoxin limits (<0.01 EU/mg), PX1 Research ensures that observed anti-inflammatory effects in downstream experiments stem entirely from the KPV molecule itself rather than background endotoxin contamination.

Laboratory Handling, Reconstitution, and Storage Protocols

Proper handling and storage protocols are required to preserve the structural integrity of synthetic KPV peptides over extended experimental timelines. KPV is supplied as a sterile, lyophilized (freeze-dried) powder in sealed glass vials to ensure maximum shelf stability.

Standard laboratory storage guidelines include:

• **Lyophilized Powder Storage:** Store unopened vials at -20°C for short-to-medium term storage, or at -80°C for long-term preservation. Protect from light and moisture exposure.

• **Reconstitution Parameters:** Reconstitute under a laminar flow hood using sterile, laboratory-grade solvents such as Water for Injection (WFI), Phosphate-Buffered Saline (PBS, pH 7.4), or Sterile Bacteriostatic Water.

• **Post-Reconstitution Handling:** Once dissolved, KPV solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles, which can cause peptide cleavage. Aliquots should be stored at -20°C or lower and brought to room temperature immediately prior to assay execution.

Procurement and Institutional Ordering Options

PX1 Research is dedicated to supporting academic institutions, biotechnology organizations, and contract research organizations (CROs) with dependable access to analytical-grade research peptides. All orders ship directly from our state-of-the-art dispatch centers located in California and Arizona, featuring same-day fulfillment for orders placed Monday through Friday before 12:00 PM PST.

For universities and commercial entities requiring high-volume peptide synthesis or custom lot reservations, PX1 Research provides dedicated support via our wholesale research account portal. Explore our complete catalog of research peptides to source standardized, fully verified compounds for your laboratory's ongoing experimental needs.